POU5F1 and renal cell carcinoma: In the present study, for the first time, the expression levels of both OCT4 and NANOG were investigated in a well- characterized series of 186 tissues samples from 3 main subtypes of RCC; moreover, the impact of OCT4 and NANOG coexpression in RCC prognosis was evaluated.